AIM ImmunoTech, Inc. (AIM)
0.8107
-0.03
(-3.91%)
USD |
NYAM |
Feb 12, 16:00
0.8107
0.00 (0.00%)
After-Hours: 20:00
AIM ImmunoTech Profit Margin (Quarterly) : -12.63K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 49.46% |
| Agenus, Inc. | -- |
| Curis, Inc. | -243.4% |
| LadRx Corp. | -- |
| Plus Therapeutics, Inc. | -316.6% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -97.29% |
| Gross Profit Margin (Quarterly) | -369.2% |
| Operating Margin (Quarterly) | -9.10K% |
| Return on Net Operating Assets | -530.3% |